These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27299187)

  • 1. Flat Urothelial Lesions With Atypia: Interobserver Concordance and Added Value of Immunohistochemical Profiling.
    Lawless ME; Tretiakova MS; True LD; Vakar-Lopez F
    Appl Immunohistochem Mol Morphol; 2018 Mar; 26(3):180-185. PubMed ID: 27299187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical staining patterns of Ki-67 and p53 in florid reactive urothelial atypia and urothelial carcinoma in situ demonstrate significant overlap.
    Nguyen JK; Przybycin CG; McKenney JK; Magi-Galluzzi C
    Hum Pathol; 2020 Apr; 98():81-88. PubMed ID: 32142835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urothelial dysplasia of the bladder: diagnostic features and clinical significance.
    Lopez-Beltran A; Montironi R; Vidal A; Scarpelli M; Cheng L
    Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):121-9. PubMed ID: 24344498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa.
    Gunia S; Kakies C; Erbersdobler A; Koch S; May M
    J Clin Pathol; 2012 Aug; 65(8):715-20. PubMed ID: 22554964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplasia and carcinoma in situ of the urinary bladder.
    Lopez-Beltran A; Marques RC; Montironi R; Reymundo C; Fonseca J; Cheng L
    Anal Quant Cytopathol Histpathol; 2015 Feb; 37(1):29-38. PubMed ID: 26072632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flat intraepithelial lesions of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Bostwick DG
    Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry in the workup of bladder biopsies: Frequency, variation and utility of use at an academic center.
    McIntire P; Khan R; Kilic I; Wojcik EM; Pambuccian SE; Barkan GA
    Ann Diagn Pathol; 2019 Aug; 41():124-128. PubMed ID: 31238192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CK20 and p53 Immunohistochemical Staining Patterns in Urinary Bladder Specimens With Equivocal Atypia.
    Arias-Stella JA; Shah AB; Gupta NS; Williamson SR
    Arch Pathol Lab Med; 2018 Jan; 142(1):64-69. PubMed ID: 28967804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could double stain for p53/CK20 be a useful diagnostic tool for the appropriate classification of flat urothelial lesions?
    Di Sciascio L; Ambrosi F; Franceschini T; Giunchi F; Franchini E; Massari F; Bianchi FM; Colecchia M; Fiorentino M; Ricci C
    Pathol Res Pract; 2022 Jun; 234():153937. PubMed ID: 35561522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An approach to the diagnosis of flat intraepithelial lesions of the urinary bladder using the World Health Organization/ International Society of Urological Pathology consensus classification system.
    Amin MB; McKenney JK
    Adv Anat Pathol; 2002 Jul; 9(4):222-32. PubMed ID: 12072813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lewis(y) antigen (blood group 8, BG8) is a useful marker in the histopathological differential diagnosis of flat urothelial lesions of the urinary bladder.
    Gunia S; Kakies C; May M; Koch S; Erbersdobler A
    J Clin Pathol; 2011 Aug; 64(8):672-6. PubMed ID: 21512109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens.
    McKenney JK; Desai S; Cohen C; Amin MB
    Am J Surg Pathol; 2001 Aug; 25(8):1074-8. PubMed ID: 11474293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of immunohistochemistry in the diagnosis of flat urothelial lesions: a study using CK20, CK5/6, P53, Cd138, and Her2/Neu.
    Jung S; Wu C; Eslami Z; Tanguay S; Aprikian A; Kassouf W; Brimo F
    Ann Diagn Pathol; 2014 Feb; 18(1):27-32. PubMed ID: 24321464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of urothelial carcinoma in situ using blue light cystoscopy and the utility of immunohistochemistry in blue light-positive lesions diagnosed as atypical.
    Pederzoli F; Murati Amador B; Samarska I; Lombardo KA; Kates M; Bivalacqua TJ; Matoso A
    Hum Pathol; 2019 Aug; 90():1-7. PubMed ID: 31071342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urothelial carcinoma in situ: diagnostic update.
    McKenney JK
    Pathology; 2021 Jan; 53(1):86-95. PubMed ID: 33234229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia.
    Aron M; Luthringer DJ; McKenney JK; Hansel DE; Westfall DE; Parakh R; Mohanty SK; Balzer B; Amin MB
    Am J Surg Pathol; 2013 Dec; 37(12):1815-23. PubMed ID: 24225842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases.
    Oliva E; Pinheiro NF; Heney NM; Kaufman DS; Shipley WU; Gurski C; Spicer B; Paner GP; Gown AM; Amin MB
    Hum Pathol; 2013 May; 44(5):860-6. PubMed ID: 23199526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of cytokeratin 5/6, cytokeratin 20, and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia.
    Edgecombe A; Nguyen BN; Djordjevic B; Belanger EC; Mai KT
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):264-71. PubMed ID: 22498670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features.
    Hodges KB; Lopez-Beltran A; Davidson DD; Montironi R; Cheng L
    Hum Pathol; 2010 Feb; 41(2):155-62. PubMed ID: 19762067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.